vimarsana.com

Latest Breaking News On - Honorary consultant nephrologist - Page 4 : vimarsana.com

Boehringer Ingelheim: Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance in reducing kidney disease progression or cardiovascular death by 28% vs placebo in people with chronic kidney disease

EMPA-KIDNEY, the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease, provides new evidence for patients commonly seen in clinical practice1,2 Phase III trial also demonstrated

Stephan thalenRichard haynesLulu phillipsAnne whitehouseEli lillyWilliam herringtonSarah muellerCarinne brouillonJeff emmickProduct developmentOxford population healthBoehringer ingelheimLilly allianceNew england journalAssociate professorHonorary consultant nephrologist

Fourth Covid-19 Shot Is Coming For The United Kingdom, Prime Minister Boris Johnson Reveals

A fourth dose of the vaccination is said to be rolled out to all Brits by the end of this year in autumn

United kingdomCharisa bossinakisRussell hart alamyBoris johnsonHonorary consultant nephrologist at imperial college healthcareCommittee on vaccinationDr michelle willicombeBoris johnson saysJohnson saysBritish prime ministerHealth secretary sajidjavidJoint committeeAlamy live newsSenior clinical lecturerHonorary consultant nephrologistImperial college healthcare

Empagliflozin trial halted after successful outcome in CKD

An early halt has been called to a major kidney drug trial following positive results for patients with chronic kidney disease (CKD).

Richard haynesWilliam herringtonWaheed jamalBoehringer ingelheim eli lillyClinician scientist oxford population healthUniversity of oxfordBoehringer ingelheimPopulation health research unitEli lillyHealth research unitAssociate professor william herringtonHonorary consultant nephrologistProfessor richard haynesPrincipal investigatorCorporate vice presidentCardiometabolic medicine

Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

Press release content from Business Wire. The AP news staff was not involved in its creation.

Rheinland pfalzUnited statesStephan thalenRichard haynesColin baigentWaheed jamalSarah reimerAnne whitehouseEli lillyMartin landrayWilliam herringtonJeff emmickUniversity of oxfordSteering committeeOxford population healthBoehringer ingelheim

Pioneering kidney disease research at Leicester receives a major boost on World Kidney Day

Pioneering research by the University of Leicester into chronic kidney disease has received a major boost on World Kidney Day (10th March 2022) following a generous £1million donation from long-term supporter and kidney health advocate Jimmy Mayer.

United kingdomPhilip bakerEmily hendersonJimmy mayerJonathan barrattUniversity of leicesterCollege of life sciencesMayer iga nephropathy laboratoryRenal research groupUnited kingdom iga nephropathy patient communityKidney research united kingdomWorld kidney dayIga nephropathyLife sciencesHonorary consultant nephrologistUniversity hospitals

vimarsana © 2020. All Rights Reserved.